论文部分内容阅读
目的探讨经尿道等离子电切加丝裂霉素方案(TURBt+MMC)治疗腺性膀胱炎的疗效。方法对80例确诊为腺性膀胱炎的患者行经尿道等离子电切术,术后行丝裂霉素C做膀胱灌注化疗,并定期行膀胱镜检。结果其中76例随访10~18(平均14)个月,痊愈57例(75.0%),好转8例(10.5%),无效或复发行第二次电切11例(14.4%)。结论 TURBt+MMC方案创伤小,不良反应少,安全有效,是治疗腺性膀胱炎最有效的方法之一。
Objective To investigate the efficacy of transurethral plasmakinetic plus mitomycin (TURBt + MMC) in treatment of cystitis glandularis. Methods Eighty patients diagnosed as cystitis glandula were treated with transurethral resection of the urethra. After operation, mitomycin C was given intravesical instillation chemotherapy and cystoscopy was performed regularly. Results 76 patients were followed up for 10 ~ 18 months (mean 14 months), 57 cases (75.0%) were cured, 8 cases (10.5%) were cured, and 11 cases (14.4%) were invalid or relapsed after the second resection. Conclusion TURBt + MMC is less invasive, less adverse reactions and safe and effective. It is one of the most effective ways to treat cystitis glandularis.